Patent holdings for IPC class B01D 15/34

Total number of patents in this class: 346

10-year publication summary

16
31
31
40
31
30
36
27
33
20
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Waters Technologies Corporation
1705
25
Kashiv Biosciences, LLC
92
11
Regeneron Pharmaceuticals, Inc.
4335
10
Cytiva BioProcess R&D AB
309
10
Cytosorbents Corporation
95
8
Genzyme Corporation
1279
7
Bio-Rad Laboratories, Inc.
1617
6
Pierce Biotechnology, Inc.
145
6
Spark Therapeutics, Inc.
168
6
Cytiva Sweden AB
763
6
International Business Machines Corporation
61471
5
Amgen Inc.
4105
5
Dow Global Technologies LLC
10413
5
Daicel Corporation
2376
4
Merck Millipore Ltd.
36
4
Kbio Holdings Limited
21
4
Resonac Corporation
2905
4
F. Hoffmann-La Roche AG
7947
3
BASF SE
20991
3
Agilent Technologies, Inc.
2638
3
Other owners 211